169
Views
0
CrossRef citations to date
0
Altmetric
CLINICAL TRIAL REPORT

Combined Phacoemulsification and STREAMLINE Surgical System Canal of Schlemm Transluminal Dilation in Eyes of Hispanic Patients with Mild to Moderate Glaucoma

ORCID Icon, &
Pages 1911-1918 | Received 01 Mar 2023, Accepted 08 Jun 2023, Published online: 04 Jul 2023

References

  • Lim R. The surgical management of glaucoma: a review. Clin Exp Ophthalmol. 2022;50:213–231. doi:10.1111/ceo.14028
  • Birnbaum FA, Neeson C, Sola-Del Valle D. Microinvasive glaucoma surgery: an evidence-based review. Semin Ophthalmol. 2021;36(8):772–786. doi:10.1080/08820538.2021.1903513
  • Pereira ICF, van de Wijdeven R, Wyss HM, Beckers HJM, den Toonder JMJ. Conventional glaucoma implants and the new MIGS devices: a comprehensive review of current options and future directions. Eye. 2021;35:3202–3221. doi:10.1038/s41433-021-01595-x
  • Gedde SJ, Feuer WJ, Lim KS, et al. Treatment outcomes in the primary tube versus trabeculectomy study after 3 years of follow-up. Ophthalmology. 2020;127:333–345. doi:10.1016/j.ophtha.2019.10.002
  • Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153:804–814. doi:10.1016/j.ajo.2011.10.024
  • Grant WM. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol. 1963;69:783–801. doi:10.1001/archopht.1963.00960040789022
  • Maepea O, Bill A. Pressures in the juxtacanalicular tissue and Schlemm’s canal in monkeys. Exp Eye Res. 1992;54:879–883. doi:10.1016/0014-4835(92)90151-H
  • Allingham RR, de Kater AW, Ethier CR. Schlemm’s canal and primary open angle glaucoma: correlation between Schlemm’s canal dimensions and outflow facility. Exp Eye Res. 1996;62:101–109. doi:10.1006/exer.1996.0012
  • Battista SA, Lu Z, Hofmann S, Freddo T, Overby DR, Gong H. Reduction of the available area for aqueous humor outflow and increase in meshwork herniations into collector channels following acute IOP elevation in bovine eyes. Invest Ophthalmol Vis Sci. 2008;49:5346–5352. doi:10.1167/iovs.08-1707
  • Rodriguez J, Sanchez R, Munoz B, et al. Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics. Ophthalmology. 2002;109:737–743. doi:10.1016/S0161-6420(01)01008-9
  • Kapetanakis VV, Chan MP, Foster PJ, Cook DG, Owen CG, Rudnicka AR. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol. 2016;100:86–93. doi:10.1136/bjophthalmol-2015-307223
  • Stein JD, Talwar N, Laverne AM, Nan B, Lichter PR. Racial disparities in the use of ancillary testing to evaluate individuals with open-angle glaucoma. Arch Ophthalmol. 2012;130(12):1579–1588. doi:10.1001/archophthalmol.2012.1325
  • Stein JD, Ayyagari P, Sloan FA, Lee PP. Rates of glaucoma medication utilization among persons with primary open-angle glaucoma, 1992 to 2002. Ophthalmology. 2008;115(8):1315–9, 9 e1. doi:10.1016/j.ophtha.2007.12.017
  • Lazcano-Gomez G, Garg SJ, Yeu E, Kahook MY. Interim analysis of STREAMLINE((R)) surgical system clinical outcomes in eyes with glaucoma. Clin Ophthalmol. 2022;16:1313–1320. doi:10.2147/OPTH.S358871
  • New World Medical. Streamline Surgical System Instructions for Use. Rancho Cucamonga, CA: New World Medical; 2021.
  • Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118:459–467. doi:10.1016/j.ophtha.2010.07.007
  • Ahmed IIK, Fea A, Au L, et al. A prospective randomized trial comparing Hydrus and iStent microinvasive glaucoma surgery implants for standalone treatment of open-angle glaucoma: the COMPARE study. Ophthalmology. 2020;127:52–61. doi:10.1016/j.ophtha.2019.04.034
  • Samuelson TW, Sarkisian SR Jr, Lubeck DM, et al. Prospective, randomized, controlled pivotal trial of an ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmology. 2019;126:811–821. doi:10.1016/j.ophtha.2019.03.006
  • Samuelson TW, Chang DF, Marquis R, et al. A schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: the HORIZON study. Ophthalmology. 2019;126:29–37. doi:10.1016/j.ophtha.2018.05.012
  • Hughes T, Traynor M. Clinical results of ab interno canaloplasty in patients with open-angle glaucoma. Clin Ophthalmol. 2020;14:3641–3650. doi:10.2147/OPTH.S275087
  • Ondrejka S, Korber N. 360 degrees ab-interno Schlemm’s canal viscodilation in primary open-angle glaucoma. Clin Ophthalmol. 2019;13:1235–1246. doi:10.2147/OPTH.S203917
  • Tracer N, Dickerson JE Jr, Radcliffe NM. Circumferential viscodilation ab interno combined with phacoemulsification for treatment of open-angle glaucoma: 12-month outcomes. Clin Ophthalmol. 2020;14:1357–1364. doi:10.2147/OPTH.S252965
  • Gillmann K, Aref A, Niegowski LJ, Baumgartner JM. Combined ab interno viscocanaloplasty (ABiC) in open-angle glaucoma: 12-month outcomes. Int Ophthalmol. 2021;41:3295–3301. doi:10.1007/s10792-021-01891-1
  • Kazerounian S, Zimbelmann M, Lortscher M, Hommayda S, Tsirkinidou I, Muller M. Canaloplasty ab interno (AbiC) - 2-year-results of a novel Minimally Invasive Glaucoma Surgery (MIGS) technique. Klin Monbl Augenheilkd. 2021;238(10):1113–1119. doi:10.1055/a-1250-8431
  • Davids AM, Pahlitzsch M, Boeker A, Winterhalter S, Maier-Wenzel AK, Klamann M. Ab interno canaloplasty (ABiC)-12-month results of a new minimally invasive glaucoma surgery (MIGS). Graefes Arch Clin Exp Ophthalmol. 2019;257:1947–1953. doi:10.1007/s00417-019-04366-3
  • Gallardo MJ, Supnet RA, Ahmed IIK. Circumferential viscodilation of Schlemm’s canal for open-angle glaucoma: ab-interno vs ab-externo canaloplasty with tensioning suture. Clin Ophthalmol. 2018;12:2493–2498. doi:10.2147/OPTH.S178962
  • Gallardo MJ, Supnet RA, Ahmed IIK. Viscodilation of Schlemm’s canal for the reduction of IOP via an ab-interno approach. Clin Ophthalmol. 2018;12:2149–2155. doi:10.2147/OPTH.S177597
  • Gallardo MJ. 24-month efficacy of viscodilation of Schlemm’s Canal and the distal outflow system with iTrack ab-interno canaloplasty for the treatment of primary open-angle glaucoma. Clin Ophthalmol. 2021;15:86–89. doi:10.2147/OPTH.S272506
  • Gallardo MJ. 36-month effectiveness of ab-interno canaloplasty standalone versus combined with cataract surgery for the treatment of open-angle glaucoma. Ophthalmol Glaucoma. 2022;5(5):476–482. doi:10.1016/j.ogla.2022.02.007
  • Koerber N, Ondrejka S. Four-year efficacy and safety of iTrack ab-interno canaloplasty as a standalone procedure and combined with cataract surgery in open-angle glaucoma. Klin Monbl Augenheilkd. 2022. doi:10.1055/a-1737-4149
  • Ahmed IIK, Rhee DJ, Jones J, et al. Three-year findings of the HORIZON trial: a schlemm canal microstent for pressure reduction in primary open-angle glaucoma and cataract. Ophthalmology. 2021;128(6):857–865.
  • Lass JH, Benetz BA, He J, et al. Corneal endothelial cell loss and morphometric changes 5 years after phacoemulsification with or without CyPass micro-stent. Am J Ophthalmol. 2019;208:211–218. doi:10.1016/j.ajo.2019.07.016
  • Ianchulev T, Lane S, Masis M, et al. Corneal endothelial cell density and morphology after phacoemulsification in patients with primary open-angle glaucoma and cataracts: 2-year results of a randomized multicenter trial. Cornea. 2019;38:325–331. doi:10.1097/ICO.0000000000001826
  • Jones J, Koch DD, Vold S, et al. Results from the United States cohort of the HORIZON trial of a Schlemm canal microstent to reduce intraocular pressure in primary open-angle glaucoma. J Cataract Refract Surg. 2019;45:1305–1315. doi:10.1016/j.jcrs.2019.03.024
  • Gillmann K, Bravetti GE, Rao HL, Mermoud A, Mansouri K. Impact of combined XEN gel stent implantation on corneal endothelial cell density: 2-year results. J Glaucoma. 2020;29:155–160. doi:10.1097/IJG.0000000000001430
  • Coleman AL, Lum FC, Velentgas P, Su Z, Gliklich RE, GORSG R. Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study. J Comp Eff Res. 2016;5:87–98. doi:10.2217/cer.15.58
  • Jung JL, Isida-Llerandi CG, Lazcano-Gomez G, SooHoo JR, Kahook MY. Intraocular pressure control after trabeculectomy, phacotrabeculectomy and phacoemulsification in a Hispanic population. J Curr Glaucoma Pract. 2014;8:67–74. doi:10.5005/jp-journals-10008-1164
  • Gallardo MJ, Supnet RA, Giamporcaro JE, Hornbeak DM. Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population. Clin Ophthalmol. 2016;10:1931–1937. doi:10.2147/OPTH.S117403
  • Armstrong JJ, Wasiuta T, Kiatos E, Malvankar-Mehta M, Hutnik CM. The effects of phacoemulsification on intraocular pressure and topical medication use in patients with glaucoma: a systematic review and meta-analysis of 3-year data. J Glaucoma. 2017;26:511–522. doi:10.1097/IJG.0000000000000643